114 related articles for article (PubMed ID: 8560394)
1. Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury.
Fullerton DA; Hahn AR; McIntyre RC
Surgery; 1996 Jan; 119(1):98-103. PubMed ID: 8560394
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation with cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung.
Fullerton DA; McIntyre RC; Mitchell MB; Campbell DN; Grover FL
J Thorac Cardiovasc Surg; 1995 Feb; 109(2):212-6; discussion 216-7. PubMed ID: 7853874
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow.
Fullerton DA; Mitchell MB; Jones DN; Maki A; McIntyre RC
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):190-7. PubMed ID: 8551766
[TBL] [Abstract][Full Text] [Related]
4. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
[TBL] [Abstract][Full Text] [Related]
5. Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung.
Fullerton DA; Mitchell MB; McIntyre RC; Banerjee A; Campbell DN; Harken AH; Grover FL
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1213-7. PubMed ID: 8246563
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of cyclic adenosine monophosphate-mediated pulmonary vasodilation by acute hypoxia.
McIntyre RC; Banerjee A; Hahn AR; Agrafojo J; Fullerton DA
Surgery; 1995 Mar; 117(3):314-8. PubMed ID: 7878538
[TBL] [Abstract][Full Text] [Related]
7. Intracellular mechanisms of pulmonary vasomotor dysfunction in acute lung injury caused by mesenteric ischemia-reperfusion.
Fullerton DA; Hahn AR; Koike K; Banerjee A; Harken AH
Surgery; 1993 Aug; 114(2):360-6; discussion 366-7. PubMed ID: 8393598
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils mediate pulmonary vasomotor dysfunction in endotoxin-induced acute lung injury.
Sheridan BC; McIntyre RC; Moore EE; Meldrum DR; Agrafojo J; Fullerton DA
J Trauma; 1997 Mar; 42(3):391-6; discussion 396-7. PubMed ID: 9095105
[TBL] [Abstract][Full Text] [Related]
9. KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
Am J Physiol; 1997 Nov; 273(5):L950-6. PubMed ID: 9374721
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of coronary vasomotor dysfunction in the transplanted heart.
Fullerton DA; Mitchell MB; McIntyre RC; Brown JM; Meng X; Campbell DN; Grover FL
Ann Thorac Surg; 1994 Jul; 58(1):86-91; discussion 91-2. PubMed ID: 8037566
[TBL] [Abstract][Full Text] [Related]
11. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Nakazawa H; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
[TBL] [Abstract][Full Text] [Related]
13. Magnesium is essential in mechanisms of pulmonary vasomotor control.
Fullerton DA; Hahn AR; Agrafojo J; Sheridan BC; McIntyre RC
J Surg Res; 1996 Jun; 63(1):93-7. PubMed ID: 8661179
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations.
McIntyre RC; Sheridan B; Agrafojo J; Fullerton DA
Crit Care Med; 1997 Feb; 25(2):318-23. PubMed ID: 9034271
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated neutrophil depletion preserves pulmonary vasomotor function.
Sheridan BC; McIntyre RC; Meldrum DR; Cleveland JC; Agrafojo J; Eisenach JH; Harken AH; Fullerton DA
J Surg Res; 1996 Apr; 62(1):74-8. PubMed ID: 8606514
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
J Surg Res; 1997 Aug; 71(2):145-9. PubMed ID: 9299282
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
[TBL] [Abstract][Full Text] [Related]
18. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
Gray DW; Marshall I
Br J Pharmacol; 1992 Nov; 107(3):684-90. PubMed ID: 1335334
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility.
McIntyre RC; Banerjee A; Agrafojo J; Fullerton DA
J Surg Res; 1995 Jun; 58(6):765-70. PubMed ID: 7791358
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
